You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054

Article metrics

Article menu

Download PDFPDF

Letter
Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054

 

Online download statistics by month:

Online download statistics by month: January 2022 to July 2025

AbstractFullPdf
Jan 2022026370
Feb 2022010635
Mar 2022011135
Apr 202208818
May 202208628
Jun 202208612
Jul 20220829
Aug 20220929
Sep 202208423
Oct 202209329
Nov 202205811
Dec 20220585
Jan 20230385
Feb 202307616
Mar 20230388
Apr 20230279
May 20230248
Jun 202302115
Jul 202301410
Aug 202302111
Sep 20230243
Oct 20230139
Nov 202302110
Dec 20230405
Jan 202403213
Feb 20240144
Mar 202402448
Apr 202402525
May 202402711
Jun 202402013
Jul 202403210
Aug 20240156
Sep 202402310
Oct 202402111
Nov 20240266
Dec 202404023
Jan 20250177
Feb 20250166
Mar 202502014
Apr 202506212
May 20250188
Jun 20250147
Jul 2025010
Total02011627